Booster phenomenon of QuantiFERON-TB Gold after prior intradermal PPD injection

International Journal of Tuberculosis and Lung Disease

Volumn 11, Issue 7, 2007, Pages 788-791

  Igari, Hidetoshi ^a   Watanabe, A ^a   Sato, T ^a  

^a CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Booster phenomenon; Latent tuberculosis infection; Purified protein derivative; QuantiFERON TB Gold

Indexed keywords

EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; QUANTIFERON; TUBERCULIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BOOSTER PHENOMENON; CLINICAL EFFECTIVENESS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; HUMAN; IMMUNOREACTIVITY; JAPAN; MAJOR CLINICAL STUDY; MEDICAL STUDENT; PRIORITY JOURNAL; SCREENING TEST; TUBERCULIN TEST; TUBERCULOSIS; UNIVERSITY;

ADULT; ANTIBODIES, BACTERIAL; COHORT STUDIES; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; INCIDENCE; INJECTIONS, INTRADERMAL; INTERFERON-GAMMA; JAPAN; MALE; MASS SCREENING; MYCOBACTERIUM TUBERCULOSIS; REAGENT KITS, DIAGNOSTIC; RISK ASSESSMENT; SCHOOLS, MEDICAL; SENSITIVITY AND SPECIFICITY; STUDENTS, MEDICAL; TUBERCULIN; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 34447312472     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Tufariello J M, Chan J, Flynn J L. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis 2003; 3: 578-590.
2. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161 (Suppl): S221-S247.
3. Jasmer R M, Nahid P, Hopewell P C. Clinical practice. Latent tuberculosis infection. N Engl J Med 2002; 347: 1860-1866.
4. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006; 10: 1192-1204.
5. Andersen P, Munk M E, Pollock J M, Doherty T M. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356: 1099-1104.
6. Barnes P F. Diagnosing latent tuberculosis infection: turning glitter to gold. Am J Respir Crit Care Med 2004; 170: 5-6.
7. Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004; 170: 59-64.
8. Menzies R, Vissandjee B, Rocher I, St Germain Y. The booster effect in two-step tuberculin testing among young adults in Montreal. Ann Intern Med 1994; 120: 190-198.
9. Mori T. Recent trends in tuberculosis, Japan. Emerg Infect Dis 2000; 6: 566-568.
10. Desem N, Jones S L. Development of a human gamma interferon enzyme immunoassay and comparison with tuberculin skin testing for detection of Mycobacterium tuberculosis infection. Clin Diagn Lab Immunol 1998; 5: 531-536.
11. Streeton J A, Desem N, Jones S L. Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection. Int J Tuberc Lung Dis 1998; 2: 443-450.
12. Rothel J S, Radford A J. Comparison of tuberculosis tests: finding truth or confirming prejudice. Clin Infect Dis 2003; 36: 1206-1207.
13. Mawa P A, Pickering J M, Miiro G, et al. The effect of tuberculin skin testing on viral load and antimycobacterial immune responses in HIV-1-infected Ugandan adults. Int J Tuberc Lung Dis 2004; 8: 586-592.
14. Leyten E M, Prins C, Bossink A W, et al. Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific IFN-γ assay. Eur Respir J 2007; 23: 1212-1216.